Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
Rhea-AI Summary
Inspire Medical Systems (NYSE:INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference.
The company's management team will deliver their presentation on Wednesday, September 3, 2025, at 11:00 a.m. Eastern Time. Investors can access the presentation through a live webcast, with a replay available for two weeks afterward on the company's investor website at investors.inspiresleep.com.
Positive
- None.
Negative
- None.
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443